HOME >> MEDICINE >> NEWS
Taking painkillers during pregnancy increases risk of miscarriage

Women who take non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin during pregnancy increase their risk of miscarriage by 80 per cent, finds a study in this week's BMJ.

Researchers in California interviewed 1,055 pregnant women immediately after their pregnancy was confirmed. They asked the women about their drug use since they became pregnant, their reproductive history, known or potential risk factors for miscarriage, and sociodemographic characteristics.

They found that use of NSAIDs during pregnancy increased the risk of miscarriage by 80%. The risk was much higher when NSAIDs were taken around conception or were used for longer than a week. Taking account of other factors, including drinking alcohol or coffee, did not change the results.

Aspirin was similarly associated with an increased risk of miscarriage but paracetamol was not, regardless of timing and duration of use.

All three drugs work by suppressing the production of prostaglandins (fatty acids needed for successful implantation of an embryo in the womb). Because NSAIDs and aspirin act on the whole body, they could lead to abnormal implantation that predisposes an embryo to miscarriage. In contrast, paracetamol acts only in the central nervous system, which may explain why it has no effect on risk of miscarriage, explain the authors.

These findings will need confirmation, say the authors. Meanwhile, it may be prudent for physicians and women who are planning to be pregnant to be aware of this potential risk and avoid using NSAIDs around conception.


'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-0-207-383-6529
BMJ-British Medical Journal
14-Aug-2003


Page: 1

Related medicine news :

1. Taking a number of medications regularly could give you a serious headache
2. Taking pills, even if placebo, predicts better survival in heart failure
3. Taking apart a hurricane: Multi-sensor Envisat sees through Frances
4. Taking vitamins to lower amino acid level in blood does not reduce the risk of recurrent stroke
5. Taking vitamin D supplements lowers risk of multiple sclerosis
6. Taking Ecstasy during pregnancy may cause brain damage, behavior problems in babies
7. Taking control: Lab testing you order for yourself
8. Taking public health to the streets works
9. Adolescents And Risk-Taking: A Very Likely Danger May Not Mean The Same To A Teen As To An Adult
10. Medical Students Are Taking Risks With HIV During Elective Studies
11. Infants To Seniors: Seven Years Follow-Up Of 1,000 Liver Transplant Patients Taking Tacrolimus Indicates Children Have Best Survival

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... practice partnerships through affiliations and de novo development, today announced Cumberland Skin ... , Cumberland Skin Surgery and Dermatology, with offices in both Hermitage and Lebanon, ...
(Date:8/16/2017)... ... August 16, 2017 , ... The ... a three-year grant totaling $975,000, renewing its funding from the Health Resources and ... , This funding marks, the fourth time the HRSA administration has renewed its ...
(Date:8/16/2017)... ... , ... A global leader in the treatment of clubfoot, CURE International ... states—bringing the country one step closer to eliminating clubfoot as a lifelong disability by ... track to enroll 10,000 children in the clubfoot treatment program in this year alone. ...
(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s ... Economist Intelligence Unit’s (EIU) annual Liveability Index. , The Index surveys 140 of the ... began in 2006, Melbourne has consistently come in the top three of the index. ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... $5.99, eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery ... of God's love, and all the many ways God shows love to those ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... 2017  West Pharmaceutical Services, Inc. (NYSE: ... second-quarter 2017 and updated financial guidance for the full-year ... Highlights Reported net sales of $397.6 ... quarter. Net sales at constant currency (organic) grew by ... $0.51, compared to $0.60 in the prior-year quarter. Second-quarter ...
(Date:7/26/2017)... Sancilio Pharmaceuticals Company, Inc. (SPCI) today announced ... Altemia TM , an oral therapy for pediatric patients ... (SCD). The SCOT Trial, is a double-blind, placebo-controlled, dose-finding, ... Altemia TM in pediatric patients aged 5-17 years ... "The completion of ...
(Date:7/25/2017)... LAUDERDALE, Fla. , July 25, 2017  Debbie,s Dream Foundation: Curing Stomach ... Luncheon on Monday, September 25, 2017 at the Bonaventure Resort & Spa in ... ... Gendler, DDF Founder and President Debbie Zelman, and Luncheon Committee Co-chair Sabrina Kurzman. ... ...
Breaking Medicine Technology:
Cached News: